Table 1: Clinical characteristics in the study groups.

TAV ()BAV ()

Male gender (%)4659
Age (years)71.3 ± 2.53 (range 55–8462.1 ± 1.87 (range 42–79)
Aortic diameter (cm)5.6 ± 0.185.9 ± 0.16
Aortic CSA/h (cm2/m)6.6 ± 0.67.6 ± 0.6
Peak valve gradient (mmHg)83 ± 986 ± 11
Mean valve gradient (mmHg)55 ± 759 ± 9
Aortic valve area index (cm2/m2)0.39 ± 0.020.38 ± 0.02
Hypertension (%)8481
Medication
 Angiotensin receptor blockers (%)3818
 Statins (%)041
 Aspirin (%)3114

Values are means ± SEM. compared with donors; P<0.05 compared with TAV; CSA/h, ascending aortic cross-sectional area to patient height ratio.